2023

Gilead

Pharmaceutical company Gilead Sciences may pay $246 million to settle a lawsuit over the delay in the release of generic drugs

Gilead Sciences commits to pay $246.75 million to customers who have purchased Atripla or Truvada, or generic versions of these drugs over the past five years

Pharmaceutical company Gilead Sciences may pay $246 million to settle a lawsuit over the delay in the release of generic drugs Read More »

призов

Five key questions about military registration, combat operations and traveling abroad for female doctors and pharmacists

Since January 1, all medicines and pharmacists have been obligingly moving to the front line. We have selected species based on the broadest nutritional requirements for the military environment, which is what women who work in the medical room may face in the coming years.

Five key questions about military registration, combat operations and traveling abroad for female doctors and pharmacists Read More »

Meeting of the Government of Uzbekistan

The Agency for the Development of the Pharmaceutical Industry of Uzbekistan, together with USAID, is implementing a project to diversify the Asian pharmaceutical supply chain

The DAPSC will be implemented with technical assistance from the USAID Program for the Advancement of Quality Medicines Plus (PQM+).

The Agency for the Development of the Pharmaceutical Industry of Uzbekistan, together with USAID, is implementing a project to diversify the Asian pharmaceutical supply chain Read More »

Scroll to Top